85
|
305
|
7mavA |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor dffcit-yne |
45
|
182
|
7uj9A |
Room-temperature x-ray structure of monomeric sars-cov-2 main protease catalytic domain (mpro1-199) |
73
|
302
|
8dz6A |
Crystal structure of sars-cov-2 main protease mutant q189k in complex with nirmatrelvir |
82
|
304
|
7matA |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor dffr |
77
|
302
|
8dz0A |
Crystal structure of sars-cov-2 main protease in complex with ensitrelvir |
78
|
301
|
8dzaA |
Crystal structure of sars-cov-2 main protease a193t mutant in complex with nirmatrelvir |
47
|
189
|
7ujuA |
Room-temperature x-ray structure of monomeric sars-cov-2 main protease catalytic domain (mpro1-196) in complex with nirmatrelvir |
91
|
306
|
7setA |
Sars-cov-2 main protease (mpro) in complex with ml1000 |
82
|
304
|
7mb2A |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor sm144 |
49
|
185
|
7ujgA |
Room-temperature x-ray structure of monomeric sars-cov-2 main protease catalytic domain (mpro1-196) in complex with gc-376 |
78
|
302
|
8dz1A |
Crystal structure of sars-cov-2 main protease mutant m49i in complex with ensitrelvir |
88
|
306
|
7sfiA |
Sars-cov-2 main protease (mpro) in complex with ml104 |
88
|
304
|
8ehjA |
Crystal structure of sars-cov-2 main protease (mpro) h172q mutant |
89
|
302
|
8ehmA |
Crystal structure of sars-cov-2 main protease (mpro) s144f mutant |
87
|
301
|
8acdA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the non-covalent inhibitor ga-17s |
86
|
306
|
8ds0A |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp14-nsp15 (c14) cut site sequence (form 2) |
86
|
299
|
8e63A |
Crystal structure of sars-cov-2 3cl protease in complex with a phenyl sulfane inhibitor |
84
|
302
|
8ds1A |
Structure of sars-cov-2 mpro in complex with nsp12-nsp13 (c12) cut site sequence |
91
|
305
|
7sf3A |
Sars-cov-2 main protease (mpro) in complex with ml1006m |
91
|
305
|
8ehkA |
Crystal structure of sars-cov-2 main protease (mpro) t135i mutant |
88
|
301
|
8ehlA |
Crystal structure of sars-cov-2 main protease (mpro) s144m mutant |
79
|
239
|
7z05A |
White bream virus n7-methyltransferase |
82
|
306
|
8drzA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp13-nsp14 (c13) cut site sequence |
87
|
306
|
8ds2A |
Structure of sars-cov-2 mpro in complex with the nsp13-nsp14 (c13) cut site sequence (form 2) |
81
|
303
|
7sghA |
Sars-cov-2 main protease (mpro) in complex with ml124n |
87
|
306
|
7sf1A |
Sars-cov-2 main protease (mpro) in complex with ml1001 |
90
|
301
|
7sfbA |
Sars-cov-2 main protease (mpro) in complex with ml101 |
85
|
301
|
8aclA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the non-covalent inhibitor gc-14 |
95
|
306
|
7sfhA |
Sars-cov-2 main protease (mpro) in complex with ml102 |
80
|
306
|
8drwA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp9-nsp10 (c9) cut site sequence |
87
|
306
|
8drtA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp6-nsp7 (c6) cut site sequence (form 2) |
77
|
298
|
8e6aA |
Crystal structure of sars-cov-2 3cl protease in complex with a p-chlorophenylethanol based inhibitor |
78
|
303
|
8dryA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp12-nsp13 (c12) cut site sequence |
85
|
300
|
8e5zA |
Crystal structure of sars-cov-2 3cl protease in complex with a dimethyl sulfonyl benzene inhibitor |
82
|
303
|
8doxA |
Crystal structure of sars-cov-2 main protease in complex with an inhibitor tkb-245 |
84
|
302
|
8drsA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp6-nsp7 (c6) cut site sequence |
79
|
306
|
8drvA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp8-nsp9 (c8) cut site sequence |
83
|
300
|
8e69A |
Crystal structure of sars-cov-2 3cl protease in complex with a m-fluorodimethyl oxybenzene inhibitor |
77
|
306
|
8druA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp7-nsp8 (c7) cut site sequence |
86
|
302
|
8drrA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp4-nsp5 (c4) cut site sequence |
88
|
306
|
8drxA |
Product structure of sars-cov-2 mpro c145a mutant in complex with nsp10-nsp11 (c10) cut site sequence (form 2) |
82
|
298
|
8e68A |
Crystal structure of sars-cov-2 3cl protease in complex with a p-fluorodimethyl oxybenzene inhibitor |
85
|
299
|
8e65A |
Crystal structure of sars-cov-2 3cl protease in complex with a p-chlorodimethyl oxybenzene inhibitor |
85
|
298
|
8e64A |
Crystal structure of sars-cov-2 3cl protease in complex with a benzimidazole dimethyl sulfane inhibitor |
85
|
305
|
7t2tA |
Sars-cov2 mpro native form |
89
|
306
|
8e6bA |
Crystal structure of mers 3cl protease in complex with a dimethyl sulfinyl benzene inhibitor |
85
|
306
|
8e6eA |
Crystal structure of mers 3cl protease in complex with a phenyl sulfane inhibitor |
86
|
302
|
8e61A |
Crystal structure of sars-cov-2 3cl protease in complex with a m-chlorophenyl dimethyl sulfane inhibitor |
85
|
306
|
7t2vA |
Sars cov2 mpro c145s mutant |
78
|
306
|
8e6dA |
Crystal structure of mers 3cl protease in complex with a p-fluorophenyl dimethyl sulfane inhibitor |